Viagra and Pharma: A Risky Investment ?

The story of Viagra presents a intriguing case study for pharmaceutical stakeholders. Initially a phenomenal success, creating billions in revenue , the exclusivity lapse has revealed the challenges of relying on a single product. While generic versions have considerably eroded sales , questions

read more